FeesSafety
Pluang+

Woodward shares remain a hold despite strong business and growth prospects due to high valuation.

Analyst Insights
20 Nov 2026, 02:06 WIB
Seeking Alpha
View Source
Neutral
Woodward shares remain a hold despite strong business and growth prospects due to high valuation.

Woodward, Inc. continues to show strong aerospace and industrial growth, with management projecting 6%–10% revenue growth and adjusted EPS of $10.20–$10.70 for fiscal 2027. Despite these positive fundamentals and low net leverage, the stock is considered too expensive following a significant price increase, leading to a hold rating rather than a buy. A downgrade could occur if the stock price rises materially or if company fundamentals weaken. Investors should watch valuation closely against operational performance.

Woodward's growth outlook is presented here alongside Industrials-sector data from Pluang as of Nov 20, 2026 06:42 WIB. Among 135 priced US Industrials stocks, only 13 rose while 121 fell. EHang Holdings Ltd led with a 100% buy order activity at USD 2.90 and a typical hold time of 50 days, contrasting with Eos Energy Enterprises Inc at USD 1.35 facing a 71% buy order activity but a sharper 8.78% drop in one day and a shorter hold time of 19 days.

More News

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

The S&P 500 recently experienced a four-week losing streak following a record high, dropping about 8% from its peak. Historically, such declines have often been healthy pullbacks rather than signs of a bear market, with the index showing gains six an...

Market News
Bullish
1 hour ago
Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute (UTI) reported a 6% increase in fourth-quarter revenue to $235.9 million, driven by a rise in full-time students. However, net income fell nearly 4% to just over $18 million, missing analyst earnings per share estimates....

Company Fundamentals
Bearish
1 hour ago
Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Investor Michael Burry highlighted risks in CoreWeave, Nebius, Nvidia, and semiconductor stocks, noting significant price drops due to rising borrowing costs and potential long-term challenges for Nvidia's competitive edge. CoreWeave and Nebius have ...

Market News
Bearish
1 hour ago
AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD is gaining ground on Nvidia in the AI chip market, with its data center revenue nearly doubling year over year in Q3 and overall revenue up 45%. Nvidia faces leadership uncertainty after former CEO Jensen Huang's departure, creating an opportunit...

Market News
Bullish
1 hour ago
Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's investigational drug JNJ-6143, acquired through a $3.05 billion purchase of Halda Therapeutics, demonstrated a 75% overall response rate in a Phase 1 trial for metastatic castration-resistant prostate cancer. This promising early ...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App